Publication date: Available online 17 November 2026 Source: Blood Vessels, Thrombosis & Hemostasis Author(s): Samer Salem, Keith R. McCrae, Alok A. Khorana
Substantial early venous thromboembolism risk with amivantamab plus lazertinib and potential mitigation strategies. // Blood Vessels, Thrombosis & Hemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2950327226001026?dgcid=rss_sd_all
Substantial early venous thromboembolism risk with amivantamab plus lazertinib and potential mitigation strategies. Blood Vessels, Thrombosis & Hemostasis. https://www.sciencedirect.com/science/article/pii/S2950327226001026?dgcid=rss_sd_all
“Substantial early venous thromboembolism risk with amivantamab plus lazertinib and potential mitigation strategies.” Blood Vessels, Thrombosis & Hemostasis.
@article{article38420,
title = {Substantial early venous thromboembolism risk with amivantamab plus lazertinib and potential mitigation strategies},
journal = {Blood Vessels, Thrombosis \& Hemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2950327226001026?dgcid=rss_sd_all}
}